Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Lions King Hi-Tech is a leading Chinese biotech company specializing in the recycling of organic solid waste using advanced biotechnology. It has developed commercial-scale microbial fermentation processes to produce high-value functional oligosaccharides such as 2'-fucosyllactose (2'FL), 3-fucosyllactose (3-FL), sialylated lactose derivatives, LNnT, LNT and others. The company also operates large-scale biomass resource regeneration projects for green energy production including biodiesel and biogas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Lions King Hi-Tech.